Inter Pharma (Thailand) Management Evaluation
| IP Stock | THB 3.14 0.04 1.26% |
Inter Pharma employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 12 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Inspection of Inter Pharma's management performance can provide insight into the company performance.
| Trinnawat Thanitnithiphan Insider CEO Director |
| Nattarin Polpuech Insider CFO Fin |
Inter |
Inter Pharma Management Team Effectiveness
The company has return on total asset (ROA) of 0.0524 % which means that it generated a profit of $0.0524 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1031 %, meaning that it generated $0.1031 on every $100 dollars invested by stockholders. Inter Pharma's management efficiency ratios could be used to measure how well Inter Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Inter Pharma Workforce Comparison
Inter Pharma Public is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 89.0. Inter Pharma holds roughly 5.0 in number of employees claiming about 6% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. Inter Pharma Public Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Inter Pharma Public Price Series Summation is a cross summation of Inter Pharma price series and its benchmark/peer.
Inter Pharma Notable Stakeholders
An Inter Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inter Pharma often face trade-offs trying to please all of them. Inter Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inter Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Trinnawat Thanitnithiphan | CEO Director | Profile | |
| Nattarin Polpuech | CFO Fin | Profile | |
| Napaporn Dechakarat | Director Director | Profile | |
| Chompunuch Meevang | Company Sec | Profile | |
| Apimon Posri | HR Director | Profile |
About Inter Pharma Management Performance
The success or failure of an entity such as Inter Pharma Public often depends on how effective the management is. Inter Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inter management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inter management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand.
Inter Pharma Workforce Analysis
Traditionally, organizations such as Inter Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inter Pharma within its industry.Inter Pharma Manpower Efficiency
Return on Inter Pharma Manpower
| Revenue Per Employee | 181.7M | |
| Revenue Per Executive | 181.7M | |
| Net Income Per Employee | 21M | |
| Net Income Per Executive | 21M |
Other Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.